Podcast Episodes
Back to SearchTop updates in myeloma from ASH 2025: the RedirecTT-1 and MajesTEC-3 trials, dual-targeting CAR-T, trispecific antibodies, and more!
Episode 322
This podcast features key updates in multiple myeloma from ASH 2025. Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses redefi…
8 months, 3 weeks ago
Top CLL updates from ASH 2025: novel BTKi monotherapy and combination approaches, BTK degraders, & more
Episode 321
This podcast features updates in chronic lymphocytic leukemia (CLL) from ASH 2025. Talha Munir, MBBS, MRCP, FRCPath, PhD, Leeds Teaching Hospitals NH…
9 months, 2 weeks ago
Top updates in MDS from ASH 2025: key trial updates and debated topics
Episode 320
In this podcast episode, leading experts share key updates in the management of myelodysplastic syndromes (MDS) from ASH 2025. Amer Zeidan, MBBS, MHS…
9 months, 3 weeks ago
Sickle cell disease management: navigating the transition from pediatric to adult care, managing VOCs, & more
Episode 319
In this podcast episode, leading experts provide valuable insight into the management of sickle cell disease (SCD). First, Samah Babiker, MBBS, MRCP-…
10 months ago
Accelerated- and blast-phase MPNs: diagnosis, management, and current challenges
Episode 318
This episode of the VJHemOnc podcast focuses on accelerated and blast-phase myeloproliferative neoplasms (MPN-AP/BP), offering insights into their di…
10 months, 1 week ago
The value and utility of MRD in the management of adults with newly-diagnosed AML
Episode 317
This podcast features experts Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, Sanam Loghavi, MD, The University of Tex…
10 months, 2 weeks ago
Updates from iwHRMM: targeted and immune-related therapies and mechanisms of resistance
Episode 316
This episode of the VJHemOnc Podcast features discussions from the 2nd International Workshop on High-Risk Multiple Myeloma (iwHRMM 2025), held in Ch…
10 months, 3 weeks ago
Advances in immunotherapy for NHL: updates from iwNHL 2025
Episode 315
This podcast features discussions from the 22nd International Workshop on Non-Hodgkin Lymphoma (iwNHL), which took place in Cambridge, MA. The discus…
11 months ago
Reviewing recent guideline updates on the risk stratification and treatment of AML
Episode 314
In this episode of the VJHemOnc Podcast, we are joined by Shai Shimony, MD, Dana-Farber Cancer Institute, Boston, MA, and Richard Stone, MD, Dana-Far…
11 months, 2 weeks ago
The management of CLL in resource-limited settings: guideline development and ongoing projects
Episode 313
VJHemOnc recently attended the International Workshop on Chronic Lymphocytic Leukemia (XXI iwCLL 2025) in Krakow, Poland, where there was a session f…
11 months, 2 weeks ago